Methods for treating conditions associated with MASP-2 dependent complement activation

Details for Australian Patent Application No. 2005254044 (hide)

Owner University of Leicester Omeros Corporation

Inventors Tedford, Clark E.; Schwaeble, HansWilhelm; Fujita, Teizo; Parent, James B.; Stover, Cordula M.

Agent Freehills

Pub. Number AU-B-2005254044

PCT Pub. Number WO2005/123128

Priority 60/578,847 10.06.04 US

Filing date 9 June 2005

Wipo publication date 29 December 2005

Acceptance publication date 29 September 2011

International Classifications

C07K 16/40 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against enzymes

A61K 31/00 (2006.01)

A61K 38/02 (2006.01) Medicinal preparations containing peptides - Peptides of undefined number of amino acids

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 21/00 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

Event Publications

11 January 2007 PCT application entered the National Phase

  PCT publication WO2005/123128 Priority application(s): WO2005/123128

29 September 2011 Application Accepted

  Published as AU-B-2005254044

2 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005254053-Plural activating optical change toothpastes, stimuli and elements

2005254038-Three-dimensional anuloplasty ring and template